US Patent Issued to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY on June 2 for "EDB-FN as biomarker of cancer and/or brain disease and nanodrug delivery system targeting same" (South Korean, Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,766, issued on June 2, was assigned to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (Seoul, South Korea) and KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).

"EDB-FN as biomarker of cancer and/or brain disease and nanodrug delivery system targeting same" was invented by Kyuha Chong (Seoul, South Korea), Phei Er Saw (Guangdong, China) and Jungsul Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a drug delivery system with a micelle structure comprising a PEG2000-DSPE polymerized lipid and an APTEDB-PEG2000-DSPE polymer, and a preparation method thereof. The dru...